+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07283705

Evaluating BMS-986504 Combined with Chemotherapy and Surgery in MTAP-Deleted Pancreatic Cancer A Phase II Trial

Led by M.D. Anderson Cancer Center · Updated on 2026-10-05

60

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying whether the combination of BMS-986504 with chemotherapy and surgery can help control pancreatic cancer in patients with MTAP-deleted pancreatic ductal adenocarcinoma. This phase II trial evaluates three groups those with resectable or borderline resectable cancer undergoing surgery plus chemotherapy, and those with locally advanced or metastatic cancer receiving standard chemotherapy with BMS-986504. The study focuses on safety, tolerability, and disease control outcomes. Participants will receive BMS-986504 combined with chemotherapy regimens specific to their cancer stage. Cohort 1 gets BMS-986504 with gemcitabine and nab-paclitaxel for four cycles plus surgery and maintenance therapy. Cohort 2 receives BMS-986504 with gemcitabine and nab-paclitaxel for four to six months followed by maintenance BMS-986504. Cohort 3 is treated with BMS-986504 and mFOLFIRINOX for four to six months. Treatments are given by mouth or intravenous infusion as appropriate. During the study, participants will be closely monitored for safety and side effects throughout treatment and for about one year. Researchers will assess outcomes like major pathological response, complications related to surgery, progression-free survival at six months, and overall response rates. Participants will follow the study protocol including scheduled visits and examinations. The total study duration extends to October 2031, with primary outcomes measured through October 2029.

CONDITIONS

Brief Title

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Research Team

M

Maria P Morelli, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here